Shimokawa et al. targeted the LGR5+ CSC population in organoid cultures of human colorectal cancer using an inducible suicide-gene caspase 9 (iCasp9) approach [18], and demonstrated that upon iCasp9 induction, organoid-derived xenograft growth in vivo was significantly reduced. The gene discussed is LGR5; the disease is colorectal cancer.